Evidence map›Paper›PMID 33043030›Full record

ReviewFrontiers in medicine2020

Therapeutic Options Against the New Coronavirus: Updated Clinical and Laboratory Evidences.

Amélia Carolina Lopes Fernandes, Adson José Martins Vale, Fausto Pierdoná Guzen, Francisco Irochima Pinheiro, Ricardo Ney Cobucci, Eduardo Pereira de Azevedo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Development and Effects of Influenza Antiviral Drugs.Molecules (Basel, Switzerland) · 2021
    Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amélia Carolina Lopes FernandesNurse Department, Nurse School, Universidade do Estado do Rio Grande do Norte (UERN), Mossoró, Brazil.
Adson José Martins ValeTocogynecology Department, Medical School, Universidade Federal do Rio Grande do Norte (UFRN), Natal, Brazil.
Fausto Pierdoná GuzenGraduate Program of Biotechnology, Laureate International Universities - Universidade Potiguar (UnP), Natal, Brazil.
Francisco Irochima PinheiroGraduate Program of Biotechnology, Laureate International Universities - Universidade Potiguar (UnP), Natal, Brazil.
Ricardo Ney CobucciGraduate Program of Biotechnology, Laureate International Universities - Universidade Potiguar (UnP), Natal, Brazil.
Eduardo Pereira de AzevedoGraduate Program of Biotechnology, Laureate International Universities - Universidade Potiguar (UnP), Natal, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pandemic caused by the new coronavirus (SARS-Cov-2) has encouraged numerous

Indexed as

coronavirusCOVID-19drug treatmentprophylaxisSARS-CoV-2viral infection

Identifiers

PMID33043030
PMCPMC7522372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.